Galmed Pharmaceuticals Ltd. SEC filings EOCN

Galmed Pharmaceuticals Ltd. has 381 filings in SEC EDGAR's recent list, going back to Dec 31, 2013. Its latest annual report, Form 20-F, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Sep 9, 2026. The company's fiscal year ends on December 31.

Galmed Pharmaceuticals Ltd. SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Sep 9, 2026 Sep 9, 2026
6-K Current report (foreign issuer) Sep 8, 2026 Sep 8, 2026
EFFECT Filing Sep 3, 2026 —
6-K Current report (foreign issuer) Sep 3, 2026 Sep 3, 2026
POS AM Filing Sep 2, 2026 —
6-K Current report (foreign issuer) Sep 2, 2026 Jun 30, 2026
6-K Current report (foreign issuer) Sep 2, 2026 Sep 2, 2026
6-K/A Filing Aug 19, 2026 Jul 22, 2026
6-K Current report (foreign issuer) Aug 19, 2026 Aug 19, 2026
6-K Current report (foreign issuer) Aug 17, 2026 Aug 17, 2026
6-K Current report (foreign issuer) Aug 14, 2026 Aug 14, 2026
6-K Current report (foreign issuer) Jul 31, 2026 Jul 31, 2026
6-K Current report (foreign issuer) Jul 29, 2026 Jul 29, 2026
6-K Current report (foreign issuer) Jul 28, 2026 Jul 28, 2026
6-K Current report (foreign issuer) Jul 22, 2026 Jul 22, 2026
6-K Current report (foreign issuer) Jul 16, 2026 Jul 16, 2026
6-K Current report (foreign issuer) Jul 8, 2026 Jul 8, 2026
424B3 Prospectus Jun 22, 2026 —
6-K Current report (foreign issuer) Jun 22, 2026 Jun 22, 2026
POS EX Filing Jun 8, 2026 —
424B3 Prospectus Jun 8, 2026 —
6-K Current report (foreign issuer) Jun 8, 2026 Jun 8, 2026
6-K Current report (foreign issuer) Jun 2, 2026 Jun 2, 2026
6-K Current report (foreign issuer) May 14, 2026 May 14, 2026
6-K Current report (foreign issuer) May 6, 2026 May 6, 2026
6-K Current report (foreign issuer) Apr 14, 2026 Apr 14, 2026
6-K Current report (foreign issuer) Apr 9, 2026 Apr 9, 2026
EFFECT Filing Apr 1, 2026 —
POS AM Filing Mar 31, 2026 —
20-F Annual report (foreign issuer) Mar 31, 2026 Dec 31, 2025
6-K Current report (foreign issuer) Mar 5, 2026 Mar 5, 2026
6-K Current report (foreign issuer) Mar 4, 2026 Mar 4, 2026
6-K Current report (foreign issuer) Feb 9, 2026 Feb 9, 2026
6-K Current report (foreign issuer) Jan 30, 2026 Jan 30, 2026
6-K Current report (foreign issuer) Dec 8, 2025 Dec 8, 2025
6-K Current report (foreign issuer) Dec 4, 2025 Dec 4, 2025
6-K Current report (foreign issuer) Dec 1, 2025 Dec 1, 2025
6-K Current report (foreign issuer) Nov 26, 2025 Sep 30, 2025
6-K Current report (foreign issuer) Nov 18, 2025 Nov 18, 2025
6-K Current report (foreign issuer) Nov 17, 2025 Nov 17, 2025
6-K Current report (foreign issuer) Oct 29, 2025 Oct 29, 2025
6-K Current report (foreign issuer) Oct 28, 2025 Oct 28, 2025
S-8 Employee stock plan registration Sep 19, 2025 —
6-K Current report (foreign issuer) Sep 19, 2025 Sep 19, 2025
EFFECT Filing Sep 2, 2025 —
EFFECT Filing Sep 2, 2025 —
POS AM Filing Aug 28, 2025 —
POS AM Filing Aug 28, 2025 —
6-K Current report (foreign issuer) Aug 28, 2025 Jun 30, 2025
6-K Current report (foreign issuer) Aug 25, 2025 Aug 25, 2025
EFFECT Filing Aug 21, 2025 —
424B3 Prospectus Aug 21, 2025 —
CORRESP Letter to the SEC Aug 21, 2025 —
UPLOAD Letter from the SEC Aug 20, 2025 —
F-1 Registration statement (foreign issuer) Aug 18, 2025 —
6-K Current report (foreign issuer) Aug 15, 2025 Aug 15, 2025
6-K Current report (foreign issuer) Aug 14, 2025 Aug 14, 2025
6-K Current report (foreign issuer) Jul 24, 2025 Jul 24, 2025
6-K Current report (foreign issuer) May 27, 2025 May 27, 2025
6-K Current report (foreign issuer) May 22, 2025 May 22, 2025
6-K Current report (foreign issuer) May 13, 2025 May 13, 2025
6-K Current report (foreign issuer) May 6, 2025 May 6, 2025
6-K Current report (foreign issuer) Apr 28, 2025 Apr 28, 2025
6-K Current report (foreign issuer) Apr 17, 2025 Apr 17, 2025
6-K Current report (foreign issuer) Apr 15, 2025 Apr 15, 2025
6-K Current report (foreign issuer) Apr 10, 2025 Apr 10, 2025
EFFECT Filing Apr 8, 2025 —
POS AM Filing Apr 2, 2025 —
20-F Annual report (foreign issuer) Apr 2, 2025 Dec 31, 2024
6-K Current report (foreign issuer) Mar 20, 2025 Mar 20, 2025
S-8 Employee stock plan registration Jan 7, 2025 —
EFFECT Filing Nov 21, 2024 —
CORRESP Letter to the SEC Nov 20, 2024 —
UPLOAD Letter from the SEC Nov 19, 2024 —
6-K Current report (foreign issuer) Nov 14, 2024 Nov 14, 2024
F-3 Shelf registration (foreign issuer) Nov 14, 2024 —
6-K Current report (foreign issuer) Nov 14, 2024 Nov 14, 2024
EFFECT Filing Oct 28, 2024 —
424B3 Prospectus Oct 28, 2024 —
CORRESP Letter to the SEC Oct 28, 2024 —
UPLOAD Letter from the SEC Oct 28, 2024 —
F-1 Registration statement (foreign issuer) Oct 21, 2024 —
6-K Current report (foreign issuer) Oct 21, 2024 Oct 21, 2024
6-K Current report (foreign issuer) Oct 15, 2024 Oct 15, 2024
6-K Current report (foreign issuer) Sep 25, 2024 Sep 25, 2024
6-K Current report (foreign issuer) Sep 20, 2024 Sep 20, 2024
6-K Current report (foreign issuer) Sep 19, 2024 Sep 19, 2024
6-K Current report (foreign issuer) Sep 16, 2024 Sep 16, 2024
EFFECT Filing Sep 9, 2024 —
424B3 Prospectus Sep 9, 2024 —
UPLOAD Letter from the SEC Sep 9, 2024 —
CORRESP Letter to the SEC Sep 9, 2024 —
F-1 Registration statement (foreign issuer) Aug 30, 2024 —
6-K Current report (foreign issuer) Aug 30, 2024 Aug 30, 2024
6-K Current report (foreign issuer) Aug 28, 2024 Jun 30, 2024
6-K Current report (foreign issuer) Aug 27, 2024 Aug 27, 2024
6-K Current report (foreign issuer) Jul 18, 2024 Jul 18, 2024
6-K Current report (foreign issuer) Jul 11, 2024 Jul 11, 2024
6-K Current report (foreign issuer) Jun 5, 2024 Jun 5, 2024
6-K Current report (foreign issuer) May 30, 2024 May 30, 2024
20-F Annual report (foreign issuer) Apr 4, 2024 Dec 31, 2023
6-K Current report (foreign issuer) Mar 19, 2024 Mar 19, 2024
6-K Current report (foreign issuer) Mar 15, 2024 Mar 15, 2024
EFFECT Filing Nov 29, 2023 —
POS AM Filing Nov 22, 2023 —
6-K Current report (foreign issuer) Nov 22, 2023 Nov 22, 2023
6-K Current report (foreign issuer) Nov 20, 2023 Nov 20, 2023
POS AM Filing Nov 1, 2023 —
6-K Current report (foreign issuer) Sep 26, 2023 Sep 26, 2023
6-K Current report (foreign issuer) Sep 22, 2023 Sep 22, 2023
6-K/A Filing Sep 21, 2023 Sep 20, 2023
6-K Current report (foreign issuer) Sep 20, 2023 Sep 20, 2023
6-K Current report (foreign issuer) Sep 13, 2023 Sep 13, 2023
6-K Current report (foreign issuer) Aug 9, 2023 Jun 30, 2023
6-K Current report (foreign issuer) Aug 9, 2023 Aug 9, 2023
6-K Current report (foreign issuer) Aug 2, 2023 Aug 2, 2023
6-K Current report (foreign issuer) Jul 18, 2023 Jul 18, 2023
424B4 Prospectus Jul 18, 2023 —
EFFECT Filing Jul 14, 2023 —
6-K Current report (foreign issuer) Jul 14, 2023 Jul 14, 2023
F-1/A Filing Jul 13, 2023 —
CORRESP Letter to the SEC Jul 12, 2023 —
CORRESP Letter to the SEC Jul 12, 2023 —
F-1/A Filing Jul 12, 2023 —
6-K Current report (foreign issuer) Jul 10, 2023 Jul 10, 2023
FWP Free writing prospectus Jun 28, 2023 —
F-1/A Filing Jun 28, 2023 —
F-1 Registration statement (foreign issuer) Jun 16, 2023 —
6-K Current report (foreign issuer) Jun 1, 2023 Jun 1, 2023
6-K Current report (foreign issuer) May 12, 2023 May 12, 2023
6-K Current report (foreign issuer) May 11, 2023 May 11, 2023
6-K Current report (foreign issuer) May 9, 2023 May 9, 2023
6-K Current report (foreign issuer) May 4, 2023 May 4, 2023
6-K Current report (foreign issuer) May 4, 2023 May 4, 2023
6-K Current report (foreign issuer) Mar 30, 2023 Mar 30, 2023
20-F Annual report (foreign issuer) Mar 29, 2023 Dec 31, 2022
6-K Current report (foreign issuer) Feb 8, 2023 Feb 8, 2023
6-K Current report (foreign issuer) Jan 5, 2023 Jan 5, 2023
6-K Current report (foreign issuer) Jan 4, 2023 Jan 4, 2023
6-K Current report (foreign issuer) Dec 14, 2022 Dec 14, 2022
6-K Current report (foreign issuer) Nov 16, 2022 Nov 16, 2022
6-K Current report (foreign issuer) Aug 4, 2022 Jun 30, 2022
6-K Current report (foreign issuer) Jul 7, 2022 Jul 7, 2022
424B5 Prospectus supplement Jul 1, 2022 —
6-K Current report (foreign issuer) Jun 29, 2022 Jun 29, 2022
6-K Current report (foreign issuer) Jun 22, 2022 Jun 22, 2022
6-K Current report (foreign issuer) Jun 17, 2022 Jun 17, 2022
6-K Current report (foreign issuer) May 17, 2022 May 17, 2022
6-K Current report (foreign issuer) May 17, 2022 May 17, 2022
6-K Current report (foreign issuer) May 17, 2022 May 17, 2022
20-F Annual report (foreign issuer) May 2, 2022 Dec 31, 2021
6-K Current report (foreign issuer) May 2, 2022 May 2, 2022
6-K Current report (foreign issuer) Apr 28, 2022 Apr 28, 2022
6-K Current report (foreign issuer) Mar 3, 2022 Mar 3, 2022
6-K Current report (foreign issuer) Jan 11, 2022 Jan 11, 2022
6-K Current report (foreign issuer) Jan 10, 2022 Jan 10, 2022
6-K Current report (foreign issuer) Nov 8, 2021 Nov 8, 2021
6-K Current report (foreign issuer) Nov 1, 2021 Nov 1, 2021
6-K Current report (foreign issuer) Oct 12, 2021 Oct 12, 2021
6-K Current report (foreign issuer) Aug 31, 2021 Aug 31, 2021
6-K Current report (foreign issuer) Aug 23, 2021 Aug 23, 2021
6-K Current report (foreign issuer) Aug 19, 2021 Aug 19, 2021
6-K Current report (foreign issuer) Aug 16, 2021 Aug 16, 2021
6-K Current report (foreign issuer) Aug 5, 2021 Jun 30, 2021
6-K Current report (foreign issuer) Aug 2, 2021 Aug 2, 2021
6-K Current report (foreign issuer) Jul 19, 2021 Jul 19, 2021
6-K Current report (foreign issuer) Jul 2, 2021 Jul 2, 2021
6-K Current report (foreign issuer) May 13, 2021 May 13, 2021
6-K Current report (foreign issuer) May 3, 2021 May 3, 2021
EFFECT Filing Apr 1, 2021 —
CORRESP Letter to the SEC Apr 1, 2021 —
UPLOAD Letter from the SEC Mar 31, 2021 —
6-K Current report (foreign issuer) Mar 26, 2021 Mar 26, 2021
F-3 Shelf registration (foreign issuer) Mar 26, 2021 —
20-F Annual report (foreign issuer) Mar 18, 2021 Dec 31, 2020
6-K Current report (foreign issuer) Mar 18, 2021 Mar 18, 2021
6-K Current report (foreign issuer) Mar 16, 2021 Mar 16, 2021
6-K Current report (foreign issuer) Feb 18, 2021 Feb 18, 2021
424B5 Prospectus supplement Feb 18, 2021 —
6-K Current report (foreign issuer) Feb 16, 2021 Feb 16, 2021
424B5 Prospectus supplement Feb 16, 2021 —
6-K Current report (foreign issuer) Jan 26, 2021 Jan 26, 2021
6-K Current report (foreign issuer) Dec 17, 2020 Dec 17, 2020
6-K Current report (foreign issuer) Nov 12, 2020 Nov 12, 2020
6-K Current report (foreign issuer) Nov 9, 2020 Nov 9, 2020
6-K Current report (foreign issuer) Sep 9, 2020 Sep 9, 2020
6-K Current report (foreign issuer) Aug 14, 2020 Aug 14, 2020
6-K Current report (foreign issuer) Aug 6, 2020 Jun 30, 2020
6-K Current report (foreign issuer) Jul 8, 2020 Jul 8, 2020
6-K Current report (foreign issuer) Jun 19, 2020 Jun 19, 2020
6-K Current report (foreign issuer) May 21, 2020 May 21, 2020
6-K Current report (foreign issuer) May 18, 2020 May 18, 2020
6-K Current report (foreign issuer) May 15, 2020 May 15, 2020
424B5 Prospectus supplement May 15, 2020 —
6-K Current report (foreign issuer) May 14, 2020 May 14, 2020
20-F Annual report (foreign issuer) Mar 12, 2020 Dec 31, 2019
6-K Current report (foreign issuer) Mar 12, 2020 Mar 12, 2020
6-K Current report (foreign issuer) Nov 6, 2019 Nov 6, 2019
6-K Current report (foreign issuer) Oct 31, 2019 Oct 31, 2019
6-K Current report (foreign issuer) Sep 26, 2019 Sep 26, 2019

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
EOCN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Ramat Gan, Israel
SEC filer status
Non-accelerated filer
SEC CIK
1595353

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.